-
公开(公告)号:CA2587112A1
公开(公告)日:2001-01-04
申请号:CA2587112
申请日:2000-06-23
Applicant: BASF AG
Inventor: SCHROEDER HARTWIG , LEE HEUNG-SHICK , ZELDER OSKAR , KROEGER BURKHARD , KIM HYUNG-JOON , HABERHAUER GREGOR , POMPEJUS MARKUS
-
142.
公开(公告)号:CA2584021A1
公开(公告)日:2001-01-04
申请号:CA2584021
申请日:2000-06-23
Applicant: BASF AG
Inventor: ZELDER OSKAR , HABERHAUER GREGOR , POMPEJUS MARKUS , KROEGER BURKHARD , SCHROEDER HARTWIG
-
143.
公开(公告)号:CA2583703A1
公开(公告)日:2001-01-04
申请号:CA2583703
申请日:2000-06-23
Applicant: BASF AG
Inventor: KROEGER BURKHARD , POMPEJUS MARKUS , ZELDER OSKAR , SCHROEDER HARTWIG , HABERHAUER GREGOR
-
144.
公开(公告)号:CA2563004A1
公开(公告)日:2001-01-04
申请号:CA2563004
申请日:2000-06-23
Applicant: BASF AG
Inventor: HABERHAUER GREGOR , SCHROEDER HARTWIG , POMPEJUS MARKUS , KROEGER BURKHARD , ZELDER OSKAR
IPC: C12N15/61 , C12N1/21 , C12N9/90 , C12N15/31 , C12N15/63 , C12P5/00 , C12P7/00 , C12P7/64 , C12P13/04 , C12P19/00 , C12P19/30 , C12P19/36 , C12P21/00 , C12Q1/04 , C12Q1/68 , G01N33/569
Abstract: Isolated nucleic acid molecules, designated SMP nucleic acid molecules, which encode novel SMP proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SMP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated SMP proteins, mutated SMP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of SMP genes in this organism.
-
公开(公告)号:CA2380870A1
公开(公告)日:2001-01-04
申请号:CA2380870
申请日:2000-06-23
Applicant: BASF AG
Inventor: KROEGER BURKHARD , POMPEJUS MARKUS , KIM HYUNG-JOON , SCHROEDER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR , LEE HEUNG-SHICK
IPC: G01N33/53 , C07K20060101 , C07K14/34 , C12N20060101 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/00 , C12N9/18 , C12N15/09 , C12N15/31 , C12P20060101 , C12P1/04 , C12P13/04 , C12P21/02 , C12Q20060101 , C12Q1/04 , C12Q1/68 , C12R1/13 , C12R1/15 , C12R1/16 , G01N33/569 , G01N37/00
Abstract: Isolated nucleic acid molecules, designated SRT nucleic acid molecules, whic h encode novel SRT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SRT nucleic acid molecules, and host cells int o which the expression vectors have been introduced. The invention still furth er provides isolated SRT proteins, mutated SRT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desire d compound from C. glutamicum based on genetic engineering of SRT genes in thi s organism.
-
146.
公开(公告)号:DE19806872A1
公开(公告)日:1999-08-26
申请号:DE19806872
申请日:1998-02-19
Applicant: BASF AG
Inventor: SCHROEDER HARTWIG
IPC: C12N15/09 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/10 , C12N15/54 , C12N15/60 , C12P17/18 , C12R1/19 , C12N15/63 , C07H21/04 , C12N1/00 , C07D495/04
Abstract: Preparation of biotin (I) comprises expressing, in a prokaryotic or eukaryotic host capable of producing (I): (a) an S-adenosyl-methionine synthase sequence (1), of 1155 bp (reproduced); and (b) at least one of the other biotin biosynthesis genes bioS1, 2 or 3 (sequences of 1206 (3), 1215 (5) and 1221 (7) bp, respectively, reproduced). Preparation of biotin (I) comprises expressing, in a prokaryotic or eukaryotic host capable of producing (I): (a) an S-adenosyl-methionine synthase sequence (1), of 1155 bp (reproduced); and (b) at least one of the other biotin biosynthesis genes bioS1, 2 or 3 (sequences of 1206 (3), 1215 (5) and 1221 (7) bp, respectively, reproduced). The transformed cells are cultured and synthesized (I) used directly, after removal of biomass, or after purification. Independent claims are also included for the following: (1) a gene construct containing (1) and at least one of (3), (5) or (7), or their functional variants, analogs or derivatives, linked to either one or more regulatory signals for increased gene and/or protein expression, and/or to their native regulators; (2) organisms containing the construct of (a); and (3) use of the bioS3 gene (7), or its variants, analogs and derivatives, alone or in combination with other biotin synthesis genes, for production of (I).
-
公开(公告)号:CA2297381A1
公开(公告)日:1999-02-04
申请号:CA2297381
申请日:1998-07-02
Applicant: BASF AG
Inventor: SCHROEDER HARTWIG , HAUER BERNHARD
IPC: C12N15/09 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/10 , C12N15/12 , C12N15/52 , C12N15/54 , C12P17/18
Abstract: The invention relates to a gene construct containing a biotin gene with the sequence SEQ ID No. 1 or SEQ ID No. 3, and to organisms containing said gene construct, the use of these sequences or the gene construct for producing biotin and to a method for producing biotin.
-
公开(公告)号:CA2548964C
公开(公告)日:2013-10-15
申请号:CA2548964
申请日:2004-12-17
Applicant: BASF AG
Inventor: BOY MATTHIAS , KLEIN DANIELA , SCHROEDER HARTWIG
IPC: C12P13/12 , A23L1/305 , C07C319/28 , C07C323/58
Abstract: The invention relates to a method for the fermentative production of methionine, to a method for the insolation of the methionine thus formed, organic substances containing methionine occurring during insulation, to the use thereof in the production of animal food or animal food complements, in addition to the use of insolated methionine in the production of human or animal food or human or animal food complements.
-
公开(公告)号:IN439CH2008A
公开(公告)日:2008-09-19
申请号:IN439CH2008
申请日:2008-02-21
Applicant: BASF AG
Inventor: KROEGER BURKHARD , KLOPPROGGE CORINNA , HAEFNER STEFAN , SCHROEDER HARTWIG , ZELDER OSKAR
Abstract: Use of a nucleic acid (I) with promoter activity for transcribing genes, where (I) is (a) a 164 bp sequence (SEQ ID No,:1); (b) a variant of (SEQ ID No.:1) with at least 90% identity and derived by substitution, insertion or deletion of nucleotides; (c) a sequence that hybridizes to (SEQ ID No.:1) under stringent conditions; or (d) a functionally equivalent fragment of (a)-(c), is new. Independent claims are also included for : (1) use of an expression unit (EU), containing (I) and functionally linked to a sequence (X) that ensures translation of RNA, for expressing genes; (2) (I), other than sequence (1), i.e. (Ia), as new compounds; (3) EU that contain (Ia) linked to (X); (4) altering (or producing) the transcription rate of genes in a microorganism, relative to the wild type; (5) expression cassette (EC) comprising at least one EU of (1), at least one other nucleic acid sequence (to be expressed) and optionally additional gene control elements, where at least the first two are linked and the sequence being expressed is heterologous with respect to EU; (6) expression vector (EV) that contains EC; (7) genetically modified microorganisms (GMO) having, for at least one gene, an altered (or induced) transcription rate, relative to the wild type; (8) preparing biosynthetic products by culturing GMO of (7); (9) use of the sequence ggaggga (53) as a ribosome-binding site in expression units that provide expression of genes in Corynebacterium or Brevibacterium; (10) use of the sequence tagagt (52) as a -10 region for expression of genes in Corynebacterium or Brevibacterium; and (11) expression units that contain sequences (52) or (53).
-
公开(公告)号:BRPI0513227A
公开(公告)日:2008-04-29
申请号:BRPI0513227
申请日:2005-07-16
Applicant: BASF AG
Inventor: ZELDER OSKAR , KLOPPROGGE CORINNA , KROEGER BURKHARD , SCHROEDER HARTWIG , HAEFNER STEFAN
Abstract: A specific nucleic acid (I) with promoter activity is used for transcribing genes, where (I) is: (a) a sequence (1) of 178 nucleotides (reproduced); (b) a derivative of (1) with >= 90% identity, formed by substitution, insertion or deletion; (c) a sequence that hybridizes to (1) under stringent conditions; or (d) a functional fragment of (a)-(c). Independent claims are also included for: (1) use of an expression unit (EU), containing and linked to a nucleic acid (NA) that ensures translation of RNA, for expressing genes; (2) (I), except sequence (1) itself, as new compounds and EU containing it; (3) method for altering (or causing) the transcription (or expression) rate of genes in microorganisms relative to the wild type; (4) expression cassette (EC) comprising EU, at least one other functionally linked NA to be expressed and optionally other genetic control elements that are heterologous with respect to EU; (5) expression vector containing EC; (6) genetically modified microorganism (GMM) in which the transcription rate of at least one gene is altered (or caused) relative to the wild type; (7) GMM containing EU and a functionally linked gene to be expressed, where this is heterologous with respect to EU; (8) preparation of biosynthetic products (A) by culturing the GMM of (6) or (7); (9) use of the sequence aggagga (21) as ribosome-binding site in expression units for expressing genes in Corynebacterium or Brevibacterium; (10) use of the sequences ttaatt (19) or taagct (20) as -10 regions in EU for expressing genes in Corynebacterium or Brevibacterium; and (11) EU that contain (21) or at least one of (19) or (20).
-
-
-
-
-
-
-
-
-